• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Upgrade for aberrometer

Article

WaveTec Vision has introduced an upgrade and an unlimited-use pricing model for its intraoperative wavefront aberrometer (ORange).

Aliso Viejo, CA-WaveTec Vision has introduced an upgrade and an unlimited-use pricing model for its intraoperative wavefront aberrometer (ORange).

Software version 2.6 includes more than 20 new functions, with a special focus on accuracy updates and data sharing. New features include improvements to the post-refractive IOL power calculation algorithm and a warning to the user when a measurement is not consistent with the preoperative biometry of the patient.

“With [the aberrometer], cataract surgeons can now validate their lens power calculations and manage astigmatism during surgery so they can precisely predict and customize how their patients will see following the procedure,” said Tom Frinzi, WaveTec chief executive officer.

The new pricing model is designed to make custom cataract surgery more affordable and accessible to surgeons and their patients. Moving away from a per-use cost basis, practices will now be charged a flat rate of $3,000 per month for unlimited use of the technology.  Cost of the equipment is about $30,000, including the first year’s service contract; subsequent annual service contracts are priced at $3,000.

“By making it easier for surgeons both to purchase and perform . . . custom cataract surgery, we are able to assist in delivering optimal refractive outcomes to patients,” Frinzi said.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.